MAG 283

structure in first source

Also Known As:

MAG-283

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Guiseppi-Elie, Anthony: 1 article (01/2014)
2.	Wilson, A Nolan: 1 article (01/2014)

1.	Wounds and Injuries (Trauma) 01/30/2014 - "Secondly, the FEM model was used to investigate the release of a competitive protease inhibitor, MAG283, via cleavage of Acetyl-Pro-Leu-Gly\|Leu-MAG-283 by MMP9 in order to achieve targeted homeostasis of MMP-9 activity, such as in the pathophysiology of chronic wounds, via closed-loop feedback control. "

1.	Protease Inhibitors (Protease Inhibitor)
2.	prolyl-leucyl-glycine